AnalystsTimur IvannikovTimur Ivannikov's Stock Forecasts
AnalystsTimur Ivannikov
Sectors:
Industries:
Analyst Ranking
Top 39%
#2020 out of 5209 analysts
Average Return
+11.39%
Win Rate
50%4 out of 8
Risk vs Reward
Poor
Good
Timur Ivannikov's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Astria Therapeutics IncATXS | +216.88% | $3.97 | $12.58 | 2025-05-14 - 2026-01-22 | Strong Buy |
Pharvaris NvPHVS | +66.77% | $16.07 | $26.80 | 2025-05-14 - 2026-03-04 | Strong Buy |
Apellis Pharmaceuticals IncAPLS | +46.36% | $44.74 | $65.48 | 2022-03-01 - 2023-02-28 | Strong Buy |
Rocket Pharmaceuticals IncRCKT | +13.33% | $16.66 | $18.88 | 2022-07-08 - 2023-07-07 | Buy |
Timur Ivannikov Analyst Color
Get additional color on Timur Ivannikov's coverage of popular stocks
Timur Ivannikov's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $8.00 | +370.59% | Reiterates | 8 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $25.00 | -6.72% | Maintains | 10 months ago |
Astria Therapeutics IncATXS | 1 | Strong Buy | $47.00 | +273.61% | Reiterates | 10 months ago |
Rocket Pharmaceuticals IncRCKT | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 4 years ago |
Gossamer Bio IncGOSS | 1 | Buy | $19.00 | N/A | Initiates Coverage On | 4 years ago |
Apellis Pharmaceuticals IncAPLS | 1 | Strong Buy | $114.00 | N/A | Maintains | 4 years ago |
Gyre Therapeutics IncGYRE | 1 | Buy | $285.00 | N/A | Maintains | 5 years ago |
Neximmune IncNEXI | 1 | Buy | $750.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.